Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 4, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Apr 4, 2017 | Human | Unknown | Dinoprost Tromethamine | Miscarriage | Outcome Unknown |
| Apr 3, 2017 | Human | Unknown | Afoxolaner 11.3 Mg Chewable Tablets | Wheezing; Asthma | Outcome Unknown |
| Apr 3, 2017 | Human | Unknown | Spinosad; Milbemycin Oxime | Burning sensation (skin); Accidental exposure | Outcome Unknown |
| Apr 1, 2017 | Human | Unknown | Afoxolaner | Welt | Outcome Unknown |
| Apr 1, 2017 | Human | Unknown | Altrenogest Oily Solution | Vaginal haemorrhage; Cervix disorder | Ongoing |
| Apr 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Mar 31, 2017 | Human | Unknown | Selamectin | Eye stinging; Accidental exposure | Recovered/Normal |
| Mar 31, 2017 | Human | Unknown | Flunixin Meglumine Injectable | Bad taste; Containers, Damaged | Recovered/Normal |
| Mar 31, 2017 | Human | Unknown | Milbemycin Oxime | Nasal irritation | Outcome Unknown |
| Mar 30, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Mar 30, 2017 | Human | Unknown | Enrofloxacin | Application site oedema; Injection site inflammation | Recovered/Normal |
| Mar 30, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Bad taste; Application site skin change NOS | Recovered/Normal |
| Mar 28, 2017 | Human | Unknown | Maropitant Citrate | Headache; Accidental exposure | Outcome Unknown |
| Mar 28, 2017 | Human | Unknown | Maropitant Citrate | Headache; Nausea; Accidental exposure | Outcome Unknown |
| Mar 28, 2017 | Human | Unknown | Maropitant Citrate | Nausea; Light headedness; Headache; Accidental exposure | Outcome Unknown |
| Mar 28, 2017 | Human | Unknown | Maropitant Citrate | Nausea; Dizziness; Headache; Accidental exposure | Outcome Unknown |
| Mar 28, 2017 | Human | Unknown | Praziquantel; Emodepside | Burning sensation of eye; Nasal irritation; Paraesthesia localised; Cough; Ac... | Outcome Unknown |
| Mar 28, 2017 | Human | Unknown | Florfenicol/Terbinafine Hydrochloride... | Eye redness; Eye irritation | Recovered/Normal |
| Mar 28, 2017 | Human | Unknown | Eprinomectin 5 Mg/Ml Pour-On Solution | Localised rash | Recovered/Normal |
| Mar 28, 2017 | Human | Unknown | Enrofloxacin | Injection site bleeding | Recovered/Normal |
| Mar 27, 2017 | Human | Unknown | Hcg (Fd) Injectable | Injection site reaction NOS | Outcome Unknown |
| Mar 27, 2017 | Human | Unknown | Detomidine Hydrochloride | Unresponsive to stimuli; Found dead | Died |
| Mar 24, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Facial rash (For urticaria see Immune SOC) | Ongoing |
| Mar 24, 2017 | Human | Unknown | Tulathromycin | Injection site reaction NOS; Injection site pain; Injection site swelling | Outcome Unknown |
| Mar 24, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Facial rash (For urticaria see Immune SOC) | Ongoing |
| Mar 21, 2017 | Human | Unknown | Ivermectin 10 Mg/Ml Solution For Inje... | Vomiting | Recovered/Normal |
| Mar 20, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Difficulty of Use | Recovered/Normal |
| Mar 20, 2017 | Human | Unknown | Oxytetracycline Dihydrate (Oxytetracy... | Injection site lesion | Outcome Unknown |
| Mar 19, 2017 | Human | Unknown | Moxidectin | Diarrhoea; Accidental exposure | Recovered/Normal |
| Mar 19, 2017 | Human | Unknown | Enrofloxacin | Emesis (multiple); Diarrhoea | Recovered/Normal |
| Mar 18, 2017 | Human | Unknown | Selamectin | Erythema (for urticaria see Immune SOC); Pruritus; Rash; Reddening of the ski... | Outcome Unknown |
| Mar 17, 2017 | Human | Unknown | Firocoxib 57 Mg Chewable | Abdominal pain; Pruritus | Outcome Unknown |
| Mar 16, 2017 | Human | Unknown | Cyclosporine | Miscarriage | Outcome Unknown |
| Mar 16, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Dispenser, Abnormal | Recovered/Normal |
| Mar 14, 2017 | Human | Unknown | Ivermectin 10 Mg/Ml Solution For Inje... | Application site bleeding; Application site swelling; Application site pain; ... | Outcome Unknown |
| Mar 11, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Application site tingling | Outcome Unknown |
| Mar 9, 2017 | Human | Unknown | Milbemycin Oxime; Praziquantel | Hives (see also 'Skin') | Outcome Unknown |
| Mar 8, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Dispenser, Abnormal | Ongoing |
| Mar 8, 2017 | Human | Unknown | Maropitant Citrate | Injection site lesion; Ecchymosis; Injection site skin discolouration; Inject... | Outcome Unknown |
| Mar 7, 2017 | Human | Unknown | Toceranib Phosphate | Rash; Reddening of the skin; Hives (see also 'Skin') | Outcome Unknown |
| Mar 5, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Burning sensation (skin); Feelings of weakness | Outcome Unknown |
| Mar 4, 2017 | Human | Unknown | Doramectin | Delusion; Accidental exposure; Abnormal behaviour NOS; Aggressive behaviour; ... | Ongoing |
| Mar 2, 2017 | Human | Unknown | Oclacitinib Maleate | Vomiting; Nausea; Diarrhoea; Abdominal pain; Accidental exposure | Outcome Unknown |
| Mar 1, 2017 | Human | Unknown | Altrenogest Oily Solution | Menstruation absent | Ongoing |
| Mar 1, 2017 | Human | Unknown | Altrenogest Oily Solution | Menstruation absent | Ongoing |
| Mar 1, 2017 | Human | Unknown | Altrenogest Oily Solution | Menstruation absent | Ongoing |
| Mar 1, 2017 | Human | Unknown | Altrenogest Oily Solution | Menstruation absent | Ongoing |
| Mar 1, 2017 | Human | Unknown | Altrenogest Oily Solution | Menstruation absent | Ongoing |
| Mar 1, 2017 | Human | Unknown | Altrenogest Oily Solution | Menstruation absent | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.